Insider Holders & Insider Ownership - Protalix BioTherapeutics Inc. (PLX)

List of insiders holdings for Protalix BioTherapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Sheratzki Eyal
Director
10% Owner
2007-01-05 20:27:250
14,466,319
14,466,319Form 4
Bio-Cell Ltd
10% Owner
2014-09-18 17:59:190
10,066,319
10,066,319Form 4
Hurvitz Eli
Director
2009-11-13 16:30:404,898,683
4,898,683
9,797,366Form 4
Toussia-Cohen Sharon
Director
10% Owner
2007-01-05 20:28:070
6,556,381
6,556,381Form 4
Techno-Rov Holdings (1993) Ltd
10% Owner
2007-01-05 20:28:260
6,186,046
6,186,046Form 4
Marathon Investments Ltd.
10% Owner
2009-09-24 11:00:464,777,304
0
4,777,304Form 13G
Akirov Alfred
Director
2020-03-30 14:12:473,332,862
0
3,332,862Form 13G
FROST PHILLIP MD
Frost Gamma Investments Trust
10% Owner
2011-01-20 16:18:283,076,106
0
3,076,106Form 13D
Bashan Dror
PRESIDENT AND CEO
2024-04-03 17:30:27132,516
2,149,418
2,281,934Form 4
Dexcel Pharma Technologies Ltd.
Oren Dan
10% Owner
2021-06-15 09:19:552,034,117
0
2,034,117Form 13G
Camber Capital Management LLC
10% Owner
2017-02-14 12:01:141,562,933
0
1,562,933Form 13G
Manor Moshe
President & CEO
2018-09-14 16:30:401,300,000
0
1,300,000Form 4
HSIAO JANE PH D
Director
2007-02-02 18:18:061,134,060
0
1,134,060Form 4
Maimon Yossi
VP, Chief Financial Officer
2018-09-14 16:31:39700,000
0
700,000Form 4
Shaaltiel Yoseph
Executive VP, R&D
2018-09-14 16:30:18700,000
0
700,000Form 4
Rubin Eyal
Sr. VP and CFO
2024-11-05 17:00:150
660,909
660,909Form 4/A
Aviezer David
President & CEO
2012-07-18 16:31:130
418,000
418,000Form 4
Katz Iftah
VP of Operations
2007-06-13 15:50:55204,351
0
204,351Form 4
Almon Einat Brill
SVP, Chief Development Officer
2020-06-08 17:07:44196,995
0
196,995Form 4
Yanai Shlomo
Director
2014-07-24 16:35:33150,000
0
150,000Form 4
Palash Tzvi
Chief Operating Officer
2015-05-07 17:23:01125,000
0
125,000Form 4
Naos Yaron
Sr. VP, Operations
2024-09-24 17:00:07100,000
0
100,000Form 4
Bronfeld Zeev
Director
2022-09-09 17:01:49100,000
0
100,000Form 4
Forster Eliot
Director
2023-09-15 16:46:5785,715
0
85,715Form 4
Hayon Yael
VP, Research & Development
2023-08-17 16:30:2835,115
35,115
70,230Form 4
Schwartz Aharon
Director
2023-10-03 17:00:3261,676
0
61,676Form 4
Ben Zvi Shmuel
Director
2023-10-03 17:00:5061,676
0
61,676Form 4
Bar-Shalev Amos
Director
2023-10-03 17:00:5161,676
0
61,676Form 4
Melincoff Gwen A
Director
2023-10-03 17:00:5461,676
0
61,676Form 4
Boudes Pol F
Director
2023-10-03 17:00:5861,676
0
61,676Form 4
Kornberg Roger D.
Director
2008-09-08 20:26:1250,000
0
50,000Form 4
Granot David
Director
2020-01-22 17:03:2640,000
0
40,000Form 4
Lauterbach Sandra Leigh
VP, Sales & Commercial Affairs
2012-07-18 16:40:330
20,000
20,000Form 4
Lockshin Curtis
Director
2007-03-29 17:00:070
0
0Form 3
Buchris Pinhas Barel
Director
2007-01-05 19:33:150
0
0Form 3
Gross Yodfat Harel
Director
2007-07-12 17:12:040
0
0Form 3